Loading
institutionsInstitution
Sidney Kimmel Comprehensive Cancer Center at Jefferson Health
Thomas Jefferson University's NCI-designated cancer centre, known for prostate cancer biology and GUCY2C-targeted colorectal cancer immunotherapy.
Also called: SKCC Jefferson
Overview
NCI-designated since 1996, the Sidney Kimmel Comprehensive Cancer Center serves Philadelphia and southern New Jersey through Jefferson Health's hospital network. Scott Waldman identified guanylyl cyclase C (GUCY2C) as a colorectal cancer antigen and has carried vaccines and CAR-T against it into trials. Karen Knudsen, former director and later CEO of the American Cancer Society, built its androgen receptor and prostate cancer programme with urologist Leonard Gomella; Adam Dicker leads radiation oncology. The centre is a member of the NCI's cooperative group network and runs a community outreach programme across its catchment.
Location
Philadelphia, PA, US
Type
cancer center · Thomas Jefferson University
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#172 · 31 points (0 Newsweek + 15 NCI + 16 from 8 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-15.
Matched to Thomas Jefferson University Hospital, including child institutions. 242 works · 1,072 citations · 51% open access · 6% clinical trials · 2% reviews.
Oncology works per year
512022
532023
482024
542025
362026
Most works
- Harish Lavu16 works
- Danielle Thor15 works
- Vineet Polineni13 works
- Ben Brik13 works
- Charles J. Yeo11 works
- Tony Elias10 works
- Mahija Cheekati9 works
- Neethi Dasu8 works
- Tingting Zhan8 works
- Babar Bashir8 works
Most cited
- Prostate cancer and AR biology
- GUCY2C immunotherapy
- Radiation oncology
Marcia S. Brose
Chair of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson Health
Thyroid cancerKinase inhibitorsPrecision oncology
Led DECISION, the trial that made sorafenib the first approved targeted drug for radioiodine-refractory thyroid cancer.
Sidney Kimmel
Founder of the Sidney Kimmel Foundation for Cancer Research; namesake of the Johns Hopkins cancer centre and Jefferson's medical college
Cancer research philanthropyYoung investigator fundingCancer immunotherapy
The Jones Apparel founder has given $157 million to Johns Hopkins since 2001, which named its cancer centre for him, and put $50 million into the Bloomberg~Kimmel Institute for Cancer Immunotherapy in 2016.
Similar pages
- PersonJames L. Gulley
Shares Off-the-shelf cancer vaccines, National Cancer Institute (NIH), Prostate cancer.
- CompanyVeru
Shares Androgen receptor, Prostate cancer.
- InstitutionMayo Clinic Comprehensive Cancer Center in Florida
Shares Off-the-shelf cancer vaccines, National Cancer Institute (NIH), CAR-T cell therapy.
- CompanyAdventris Pharmaceuticals
- Target5-alpha-reductase type 2 (SRD5A2)
Shares Androgen receptor, Prostate cancer.
- PersonEric J. Small
Shares Androgen receptor, Prostate cancer.
- TreatmentAZD9750
Shares Androgen receptor, Prostate cancer.
- TreatmentQLH12016
Shares Androgen receptor, Prostate cancer.